Vivifrail exercise program for frail older adults with COPD
Tests the Vivifrail exercise program in older adults with COPD and frailty.
Plain-language title generated from the registry record
Registry title: Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program
Key facts
- Where
- Hanoi, VietnamSee the site
Where in Vietnam
- Hospital 198, Ministry of Public SecurityHanoi, VietnamTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National Geriatric Hospital
- Trial code
- NCT07519603
- Record updated
- 9 April 2026
- Original description
Frailty is common among older patients with chronic obstructive pulmonary disease (COPD) and is associated with poor functional outcomes and increased health risks. This study aims to determine the prevalence of frailty and to evaluate the effects of the Vivifrail exercise program on physical performance, activities of daily living, and quality of life in older COPD patients at Hospital 198, Ministry of Public Security, Vietnam.Read full original descriptionShow less
Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program
Frailty is common among older patients with chronic obstructive pulmonary disease (COPD) and is associated with poor functional outcomes and increased health risks. This study aims to determine the prevalence of frailty and to evaluate the effects of the Vivifrail exercise program on physical performance, activities of daily living, and quality of life in older COPD patients at Hospital 198, Ministry of Public Security, Vietnam.
Inclusion: Age ≥ 60 years; Diagnosis of COPD according to GOLD criteria; Clinically stable COPD (no exacerbation within the past 4 weeks); Able to participate in exercise training; Provide informed consent.
Exclusion: Severe cardiovascular disease limiting exercise; Severe cognitive impairment; Musculoskeletal disorders preventing exercise; Acute COPD exacerbation within the past 4 weeks; Participation in another clinical trial.